Back
AerSale Corp. 10K Form
Sell
20
ASLE
AerSale Corp.
Last Price:
$6.70
Seasonality Move:
1.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-04 | 10K | ASLE/AerSale Corp. Annual |
| 2021-03-16 | 10K | ASLE/AerSale Corp. Annual |
| 2020-11-03 | 10Q | ASLE/AerSale Corp. Quarterly |
| 2020-08-14 | 10Q | ASLE/AerSale Corp. Quarterly |
| 2020-05-07 | 10Q | ASLE/AerSale Corp. Quarterly |
| 2020-03-02 | 10K | ASLE/AerSale Corp. Annual |
Receive ASLE News And Ratings
See the #1 stock for the next 7 days that we like better than ASLE
ASLE Financial Statistics
Sales & Book Value
| Annual Sales: | $345.1M |
|---|---|
| Cash Flow: | $-10.6M |
| Price / Cash Flow: | 559.46 |
| Annual Sales: | $8.84 |
| Price / Book: | 0.76 |
Profitability
| EPS (TTM): | 0.12930 |
|---|---|
| Net Income (TTM): | $5.9M |
| Gross Margin: | $103.9M |
| Return on Equity: | 1.37% |
| Return on Assets: | 0.93% |
AerSale Corp. Earnings Forecast
Key AerSale Corp. Financial Ratios
-
The Gross Profit Margin over the past 7 years for ASLE is 30.12%.
-
The Selling, General & Administrative Expenses for ASLE have been equal to 27.30% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 97.47% of Operating Income.
-
The Net Earning history of ASLE is 1.70% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 4 years.
AerSale Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | ASLE |
| Website: | aersale.com |
Debt
| Debt-to-Equity Ratio: | 0.38 |
|---|---|
| Current Ratio: | 4.41 |
| Quick Ratio: | 0.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 61.13 |
|---|---|
| Forward P/E Ratio: | 10.63 |
ASLE Technical Analysis vs Fundamental Analysis
Sell
20
AerSale Corp. (ASLE)
is a Sell
Is AerSale Corp. a Buy or a Sell?
-
AerSale Corp. stock is rated a SellThe current AerSale Corp. [ASLE] share price is $6.70. The Score for ASLE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.